Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases

Springer Science and Business Media LLC - 2018
Srinivas Raman1, Keyue Ding2, Edward Chow1, Ralph M. Meyer3, Yvette M. van der Linden4, Daniel Roos5, William F. Hartsell6, Peter Hoskin7, Jackson Wu8, Abdenour Nabid9, Rick L. Haas10, Ruud Wiggenraad11, Scott Babington12, William F. Demas13, C. W. Wilson2, Rebecca Wong14, Liting Zhu2, Michael Brundage15
1Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada
2Canadian Cancer Trials Group, Cancer Research Institute, Queen’s University, Kingston, ON, Canada
3Juravinski Hospital and Cancer Centre and McMaster University, Hamilton, ON, Canada
4Leiden University Medical Centre, Leiden and Radiotherapy Institute Friesland, Leeuwarden, The Netherlands
5Royal Adelaide Hospital/University of Adelaide, Adelaide, Australia
6Northwestern Medicine Central DuPage Hospital, Warrenville, IL, USA
7Mount Vernon Hospital Cancer Centre, Middlesex, UK
8Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
9Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, QC, Canada
10Netherlands Cancer Institute – Antoni van Leeuwenhoek, Amsterdam, The Netherlands
11HMC, The Hague, Netherlands
12Christchurch Hospital, Christchurch, New Zealand
13Akron City Hospital, Northeast Ohio Medical University, Akron, OH, USA
14Princess Margaret Cancer Centre, Radiation Medicine Program, Ontario Cancer Institute University of Toronto, Toronto, ON, Canada
15Queen's University, Kingston, ON, Canada

Tóm tắt

Từ khóa


Tài liệu tham khảo

Coleman, R. E. (2006). Clinical features of metastatic bone disease and risk of skeletal morbidity. Clinical Cancer Research, 12(20), 6243s–9s.

Chow, E., Zeng, L., Salvo, N., Dennis, K., Tsao, M., & Lutz, S. (2012). Update on the systematic review of palliative radiotherapy trials for bone metastases. Clinical Oncology, 24(2), 112–124.

Wong, E., Hoskin, P., Bedard, G., Poon, M., Zeng, L., Lam, H., Vulpe, H., Tsao, M., Pulenzas, N., & Chow, E. (2014). Re-irradiation for painful bone metastases—a systematic review. Radiotherapy and Oncology, 110(1), 61–70.

Chow, E., van der Linden, Y. M., Roos, D., Hartsell, W. F., Hoskin, P., Wu, J. S., Brundage, M. D., Nabid, A., Tissing-Tan, C. J., Oei, B., & Babington, S. (2014). Single versus multiple fractions of repeat radiation for painful bone metastases: A randomized, controlled, non-inferiority trial. The Lancet Oncology, 15(2), 164–171.

Van den Beuken-van Everdingen, M. H., De Rijke, J. M., Kessels, A. G., Schouten, H. C., Van Kleef, M., & Patijn, J. (2007). Prevalence of pain in patients with cancer: A systematic review of the past 40 years. Annals of Oncology, 18(9), 1437–1449.

Teunissen, S. C., Wesker, W., Kruitwagen, C., de Haes, H. C., Voest, E. E., & de Graeff, A. (2007). Symptom prevalence in patients with incurable cancer: A systematic review. Journal of Pain and Symptom Management, 34(1), 94–104.

Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., Filiberti, A., Flechtner, H., Fleishman, S. B., de Haes, J. C., & Kaasa, S. (1993). The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365–376.

Fayers, P., & Bottomley, A. E. (2002). EORTC Quality of Life Group. Quality of life research within the EORTC—the EORTC QLQ-C30. European Journal of Cancer 38, 125–133.

Cleeland, C. S., & Ryan, K. M. The Brief Pain Inventory. https://www.mdanderson.org/education-andresearch/departments-programs-and-labs/departments-and-divisions/symptom-research/symptomassessment-tools/BPI_UserGuide . Accessed on 1 March 2016.

Furler, L. (2013). Validity and reliability of the pain questionnaire” Brief Pain Inventory”. A literature research. Pflege Zeitschrift, 66(9), 546–550.

Chow, E., Wu, J. S., Hoskin, P., Coia, L. R., Bentzen, S. M., & Blitzer, P. H. (2002). International Bone Metastases Consensus Working Party. International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. Radiotherapy and Oncology 64(3):275–280.

Maringwa, J., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., Martinelli, F., Reeve, B. B., Gotay, C., Greimel, E., & Flechtner, H. (2011). Minimal clinically meaningful differences for the EORTC QLQ-C30 and EORTC QLQ-BN20 scales in brain cancer patients. Annals of Oncology, 15, 726.

Maringwa, J. T., Quinten, C., King, M., Ringash, J., Osoba, D., Coens, C., Martinelli, F., Vercauteren, J., Cleeland, C. S., Flechtner, H., & Gotay, C. (2011). Minimal important differences for interpreting health-related quality of life scores from the EORTC QLQ-C30 in lung cancer patients participating in randomized controlled trials. Supportive Care in Cancer, 19(11), 1753–1760.

Revicki, D., Hays, R. D., Cella, D., & Sloan, J. (2008). Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology, 61(2), 102–109.

Osoba, D., Rodrigues, G., Myles, J., Zee, B., & Pater, J. (1998). Interpreting the significance of changes in health-related quality-of-life scores. Journal of Clinical Oncology, 16(1), 139–144.

Redelmeier, D. A., & Lorig, K. (1993). Assessing the clinical importance of symptomatic improvements: an illustration in rheumatology. Archives of Internal Medicine, 153(11), 1337–1342.

King, M. T. (1996). The interpretation of scores from the EORTC quality of life questionnaire QLQ-C30. Quality of Life Research, 5(6), 555–567.

Crosby, R. D., Kolotkin, R. L., & Williams, G. R. (2003). Defining clinically meaningful change in health-related quality of life. Journal of Clinical Epidemiology, 56(5), 395–407.

Wong, E., Zhang, L., Kerba, M., Arnalot, P. F., Danielson, B., Tsao, M., Bedard, G., Thavarajah, N., Cheon, P., Danjoux, C., & Pulenzas, N. (2015). Minimal clinically important differences in the EORTC QLQ-BN20 in patients with brain metastases. Supportive Care in Cancer, 23(9), 2731–2737.

Raman, S., Ding, K., Chow, E., Meyer, R. M., Nabid, A., Chabot, P., Coulombe, G., Ahmed, S., Kuk, J., Dar, A. R., & Mahmud, A. (2016). Minimal clinically important differences in the EORTC QLQ-BM22 and EORTC QLQ-C15-PAL modules in patients with bone metastases undergoing palliative radiotherapy. Quality of Life Research, 25(10), 2535–2541.

Wong, K., Zeng, L., Zhang, L., Bedard, G., Wong, E., Tsao, M., Barnes, E., Danjoux, C., Sahgal, A., Holden, L., & Lauzon, N. (2013). Minimal clinically important differences in the brief pain inventory in patients with bone metastases. Supportive Care in Cancer, 21(7), 1893–1899.

Zeng, L., Chow, E., Zhang, L., Tseng, L. M., Hou, M. F., Fairchild, A., Vassiliou, V., Jesus-Garcia, R., El-Din, M. A., Kumar, A., & Forges, F. (2012). An international prospective study establishing minimal clinically important differences in the EORTC QLQ-BM22 and QLQ-C30 in cancer patients with bone metastases. Supportive Care in Cancer, 20(12), 3307–3313.

Bedard, G., Zeng, L., Zhang, L., Lauzon, N., Holden, L., Tsao, M., Danjoux, C., Barnes, E., Sahgal, A., Poon, M., & Chow, E. (2013). Minimal clinically important differences in the Edmonton Symptom Assessment System in patients with advanced cancer. Journal of Pain and Symptom Management, 46(2), 192–200.

Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., Fayers, P. M., de Graeff, A., Hammerlid, E., Kaasa, S., & Sprangers, M. A. (2006). The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. European Journal of Cancer, 42(1), 55–64.

Chow, E., Ding, K., Parulekar, W. R., Wong, R. K., Van Der Linden, Y. M., Roos, D., Hartsell, W. F., Hoskin, P., Wu, J. S., Nabid, A., & Leer, J. W. (2016). Predictive model for survival in patients having repeat radiation treatment for painful bone metastases. Radiotherapy and Oncology, 118(3), 5475–51.

Schwartz, C. E., & Sprangers, M. A. (1999). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Social Science & Medicine, 48(11), 1531–1548.

Mitera, G., Zhang, L., Sahgal, A., Barnes, E., Tsao, M., Danjoux, C., Holden, L., & Chow, E. (2012). A survey of expectations and understanding of palliative radiotherapy from patients with advanced cancer. Clinical Oncology, 24(2), 134–138.

Chow, E., Meyer, R. M., Chen, B. E., van der Linden, Y. M., Roos, D., Hartsell, W. F., Hoskin, P., Wu, J. S., Nabid, A., Tissing-Tan, C. J., & Oei, B. (2014). Impact of reirradiation of painful osseous metastases on quality of life and function: a secondary analysis of the NCIC CTG SC. 20 randomized trial. Journal of Clinical Oncology, 32(34), 3867–3873.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Thông tin tác giả